Abiomed Inc (ABMD) 117.43 $ABMD 41.6% Return Se
Post# of 273258
Posted On: 09/02/2016 11:01:51 PM
Abiomed Inc (ABMD) 117.43 $ABMD
41.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD)
Comtex SmarTrend(R) - Wed Aug 31, 12:20AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 41.57% as of today's recent price of $119.34.
ABMD: 117.43 (-0.20)
ABIOMED Up 43.3% Since SmarTrend Uptrend Call (ABMD)
Comtex SmarTrend(R) - Tue Aug 23, 12:46PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 43.33% as of today's recent price of $120.82.
ABMD: 117.43 (-0.20)
Technical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics
PR Newswire - Thu Aug 18, 7:31AM CDT
Stock-Callers.com is currently focused on the Medical Appliances and Equipment segment, which includes companies that manufacture medical supplies such as surgical and medical instruments, dental equipment, and surgical appliances. According to IBISWorld, global revenue of this industry is about $350 billion. Let us take a look at today's lineup: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Stryker Corp. (NYSE: SYK), ABIOMED Inc. (NASDAQ: ABMD), and The Spectranetics Corp. (NASDAQ: SPNC). Sign up today and download for free the research reports for the stocks covered today at:
SPNC: 24.86 (+0.17), ABMD: 117.43 (-0.20), ZBH: 129.40 (+1.05), SYK: 115.60 (+0.37)
ABIOMED Set to Possibly Pullback After Yesterday's Rally of 2.63%
Comtex SmarTrend(R) - Tue Aug 09, 2:56PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $120.81 to a high of $123.93. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $122.98 on volume of 292,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 117.43 (-0.20)
ABIOMED Shares Up 41.9% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Mon Aug 08, 12:48PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 41.87% as of today's recent price of $119.60.
ABMD: 117.43 (-0.20)
Weight Watchers (WTW) Misses Q2 Earnings, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:00AM CDT
Weight Watchers International Inc. (WTW) reported earnings of 46 cents per share, which missed the Zacks Consensus Estimate by 3 cents.
ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), NTRI: 28.11 (-0.40), WTW: 10.26 (unch)
Acadia Healthcare (ACHC) Beats on Q2 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:34AM CDT
Shares of Acadia Healthcare Company Inc have had a crazy run since the company posted second-quarter 2016 results on Jul 29.
ACHC: 51.61 (+1.28), HCA: 76.51 (+1.35), ABMD: 117.43 (-0.20), WOOF: 71.96 (+1.12)
Abiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Abiomed reported earnings of 29 cents per share, which beat the Zacks Consensus Estimate by 7 cents.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
SmarTrend Watching for Potential Pullback in Shares of ABIOMED After 3.56% Gain
Comtex SmarTrend(R) - Fri Jul 29, 3:02PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $115.24 to a high of $119.93. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $116.45 on volume of 462,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 117.43 (-0.20)
Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), GNC: 20.74 (-0.07)
Shares of ABMD Up 42.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:54PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 42.24% as of today's recent price of $119.91.
ABMD: 117.43 (-0.20)
HCA Holdings (HCA) Beats Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:12AM CDT
HCA Holdings Inc. (HCA) reported second-quarter 2016 adjusted earnings of $1.66 per share, which beat the Zacks Consensus Estimate by 11 cents.
HCA: 76.51 (+1.35), BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), WCG: 114.28 (+1.58)
ResMed (RMD) Q4 Earnings in Line, Revenues Top Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:14AM CDT
ResMed ended fiscal 2016 on a modest note, with fourth-quarter revenues beating estimates and earnings meeting the same.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), RMD: 67.06 (-0.06)
Quality Systems (QSII) Lags Q1 Earnings, Issues FY17 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:35AM CDT
Quality Systems Inc. reported first-quarter 2017 adjusted earnings of 14 cents per share, below the Zacks Consensus Estimate of 18 cents.
ABMD: 117.43 (-0.20), ALGN: 95.78 (+2.02), AAC: 20.05 (+0.79), QSII: 11.86 (+0.08)
Thermo Fisher (TMO) Tops Q2 Earnings, Sales; Updates View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:31PM CDT
Thermo Fisher's (TMO) financial numbers squarely beat the Zacks Consensus Estimate in the second quarter
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23)
Mead Johnson (MJN) Tops Q2 Earnings, Sales Down Y/Y (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:43AM CDT
Mead Johnson's (MJN) second-quarter results were a mixed bag, with the bottom line comfortably beating the Zacks Consensus Estimate and revenues missing the same.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MJN: 84.20 (+0.88), MASI: 59.90 (+0.47)
Varian Medical (VAR) Beats Q3 Earnings & Sales; View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:15AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.22 per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a nickel.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), VAR: 96.41 (+0.52)
Edwards Lifesciences (EW) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:40AM CDT
Edwards Lifesciences Corp. (EW) saw its shares rise almost 6% in the last trading session.
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02)
41.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD)
Comtex SmarTrend(R) - Wed Aug 31, 12:20AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 41.57% as of today's recent price of $119.34.
ABMD: 117.43 (-0.20)
ABIOMED Up 43.3% Since SmarTrend Uptrend Call (ABMD)
Comtex SmarTrend(R) - Tue Aug 23, 12:46PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 43.33% as of today's recent price of $120.82.
ABMD: 117.43 (-0.20)
Technical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics
PR Newswire - Thu Aug 18, 7:31AM CDT
Stock-Callers.com is currently focused on the Medical Appliances and Equipment segment, which includes companies that manufacture medical supplies such as surgical and medical instruments, dental equipment, and surgical appliances. According to IBISWorld, global revenue of this industry is about $350 billion. Let us take a look at today's lineup: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Stryker Corp. (NYSE: SYK), ABIOMED Inc. (NASDAQ: ABMD), and The Spectranetics Corp. (NASDAQ: SPNC). Sign up today and download for free the research reports for the stocks covered today at:
SPNC: 24.86 (+0.17), ABMD: 117.43 (-0.20), ZBH: 129.40 (+1.05), SYK: 115.60 (+0.37)
ABIOMED Set to Possibly Pullback After Yesterday's Rally of 2.63%
Comtex SmarTrend(R) - Tue Aug 09, 2:56PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $120.81 to a high of $123.93. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $122.98 on volume of 292,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 117.43 (-0.20)
ABIOMED Shares Up 41.9% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Mon Aug 08, 12:48PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 41.87% as of today's recent price of $119.60.
ABMD: 117.43 (-0.20)
Weight Watchers (WTW) Misses Q2 Earnings, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:00AM CDT
Weight Watchers International Inc. (WTW) reported earnings of 46 cents per share, which missed the Zacks Consensus Estimate by 3 cents.
ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), NTRI: 28.11 (-0.40), WTW: 10.26 (unch)
Acadia Healthcare (ACHC) Beats on Q2 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:34AM CDT
Shares of Acadia Healthcare Company Inc have had a crazy run since the company posted second-quarter 2016 results on Jul 29.
ACHC: 51.61 (+1.28), HCA: 76.51 (+1.35), ABMD: 117.43 (-0.20), WOOF: 71.96 (+1.12)
Abiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Abiomed reported earnings of 29 cents per share, which beat the Zacks Consensus Estimate by 7 cents.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
SmarTrend Watching for Potential Pullback in Shares of ABIOMED After 3.56% Gain
Comtex SmarTrend(R) - Fri Jul 29, 3:02PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $115.24 to a high of $119.93. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $116.45 on volume of 462,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 117.43 (-0.20)
Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), GNC: 20.74 (-0.07)
Shares of ABMD Up 42.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:54PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 42.24% as of today's recent price of $119.91.
ABMD: 117.43 (-0.20)
HCA Holdings (HCA) Beats Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:12AM CDT
HCA Holdings Inc. (HCA) reported second-quarter 2016 adjusted earnings of $1.66 per share, which beat the Zacks Consensus Estimate by 11 cents.
HCA: 76.51 (+1.35), BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), WCG: 114.28 (+1.58)
ResMed (RMD) Q4 Earnings in Line, Revenues Top Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:14AM CDT
ResMed ended fiscal 2016 on a modest note, with fourth-quarter revenues beating estimates and earnings meeting the same.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), RMD: 67.06 (-0.06)
Quality Systems (QSII) Lags Q1 Earnings, Issues FY17 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:35AM CDT
Quality Systems Inc. reported first-quarter 2017 adjusted earnings of 14 cents per share, below the Zacks Consensus Estimate of 18 cents.
ABMD: 117.43 (-0.20), ALGN: 95.78 (+2.02), AAC: 20.05 (+0.79), QSII: 11.86 (+0.08)
Thermo Fisher (TMO) Tops Q2 Earnings, Sales; Updates View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:31PM CDT
Thermo Fisher's (TMO) financial numbers squarely beat the Zacks Consensus Estimate in the second quarter
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), TMO: 151.18 (+0.23)
Mead Johnson (MJN) Tops Q2 Earnings, Sales Down Y/Y (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:43AM CDT
Mead Johnson's (MJN) second-quarter results were a mixed bag, with the bottom line comfortably beating the Zacks Consensus Estimate and revenues missing the same.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MJN: 84.20 (+0.88), MASI: 59.90 (+0.47)
Varian Medical (VAR) Beats Q3 Earnings & Sales; View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:15AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.22 per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a nickel.
BABY: 40.64 (+0.93), ABMD: 117.43 (-0.20), MASI: 59.90 (+0.47), VAR: 96.41 (+0.52)
Edwards Lifesciences (EW) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:40AM CDT
Edwards Lifesciences Corp. (EW) saw its shares rise almost 6% in the last trading session.
ABMD: 117.43 (-0.20), EW: 115.85 (-0.02)
(0)
(0)Scroll down for more posts ▼